Correlation of major depressive disorder symptoms with FKBP5 but not FKBP4 expression in human immunodeficiency virus–infected individuals

References

• Binder E (2009). The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 34S:S186–S195.
   Google Scholar
• Beck A, Brown G (1996). BDI-II manual. San Antonio, TX:The Psychological Corporation.
   Google Scholar
• Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB, Tang Y, Gillespie CF, Heim CM, Nemeroff CB, Schwartz AC, Cubells JF, Ressler KJ (2008). Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299:1291–1305.
   PubMed Web of Science ®Google Scholar
• Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, Turner BJ, Eggan F, Beckman R, Vitiello B, Morton SC, Orlando M, Bozzette SA, Ortiz-Barron L, Shapiro M (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 58:721–728.
   PubMed Web of Science ®Google Scholar
• Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B, Papiol S, Seaman S, Lucae S, Kohli MA, Nickel T, Kunzel HE, Fuchs B, Majer M, Pfennig A, Kern N, Brunner J, Modell S, Baghai T, Deiml T, Zill P, Bondy B, Rupprecht R, Messer T, Kohnlein O, Dabitz H, Bruckl T, Muller N, Pfister H, Lieb R, Mueller JC, Lohmussaar E, Strom TM, Bettecken T, Meitinger T, Uhr M, Rein T, Holsboer F, Muller-Myhsok B (2004). Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36:1319–1325.
   PubMed Web of Science ®Google Scholar
• CHARTER Group (2009). CHARTER variables of interest—cross sectional complete. Technical report. La Jolla, CA:University of California San Diego. Available at:https://www.charterresource.ucsd.edu/images/Mimages/x-sect_cohort_rep.pdf.
   Google Scholar
• Chittiprol S, Shetty KT, Kumar AM, Bhimasenarao RS, Satishchandra P, Subbakrishna DK, Desai A, Ravi V, Satish KS, Gonzalez L, Kumar M (2007). HPA axis activity and neuropathogenesis in HIV-1 clade C infection. Front Biosci 12:1271–1277.
   PubMedGoogle Scholar
• Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK (2004). Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307–319.
   PubMed Web of Science ®Google Scholar
• Davies TH, Ning YM, Sanchez ER (2002). A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem 277:4597–4600.
   PubMed Web of Science ®Google Scholar
• Everall IP, Salaria S, Atkinson JH, Young C, Corbeil J, Grant I, Masliah E, HNRC (HIV Neurobehavioral Research Center) (2006). Diminished somatostatin gene expression in individuals with HIV and major depressive disorder. Neurology 67:1867–1869.
   PubMed Web of Science ®Google Scholar
• Heuser I, Yassouridis A, Holsboer F (1994). The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res 28:341–356.
   PubMed Web of Science ®Google Scholar
• Kendler K (1995). Genetic epidemiology in psychiatry: taking both genes and environment seriously. Arch Gen Psychiatry 15:895–899.
   Google Scholar
• Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS, National Comorbidity Survey Replication (2003). The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289:3095–3105.
   PubMed Web of Science ®Google Scholar
• Kirchheiner J, Lorch R, Lebedeva E, Seeringer A, Roots I, Sasse J, Brockmöller J (2008). Genetic variants in FKBP5 affecting response to antidepressant drug treatment. Pharmacogenomics 9:841–846.
   PubMed Web of Science ®Google Scholar
• Koenen KC, Saxe G, Purcell S, Smoller JW, Bartholomew D, Miller A, Hall E, Kaplow J, Bosquet M, Moulton S, Baldwin C (2005). Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol Psychiatry 10:1058–1059.
   PubMed Web of Science ®Google Scholar
• Lekman M, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJM, Lipsky R, Wisniewski SR, Manji H, McMahon FJ, Paddock S (2008). The FKBP5-gene in depression and treatment response—an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) cohort. Biol Psychiatry 63:1103–1110.
   PubMed Web of Science ®Google Scholar
• Pariante CM, Miller AH (2001). Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49:391–404.
   PubMed Web of Science ®Google Scholar
• Sarginson J, Lazzeroni L, Ryan H, Schatzberg A, Murphy G (2010). FKBP5 polymorphisms and antidepressant response in geriatric depression. Am J Med Genet B 153B:554–560.
   PubMed Web of Science ®Google Scholar
• Tsatsanis C, Dermitzaki E, Venihaki M, Chatzaki E, Minas V, Gravanis A, Margioris AN (2007). The corticotropin-releasing factor (CRF) family of peptides as local modulators of adrenal function. Cell Mol Life Sci 64:1638–1655.
   PubMed Web of Science ®Google Scholar
• Tatro ET, Everall IP, Kaul M, Achim CL (2009a). Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder. Brain Res 1286:1–12.
   PubMed Web of Science ®Google Scholar
• Tatro E, Everall I, Masliah E, Hult B, Lucero G, Chana G, Soontornniyomkij V, Achim C, HNRC (2009b). Differential expression of immunophilins FKBP51 and FKBP52 in the frontal cortex of HIV-infected patients with major depressive disorder. J Neuroimmune Pharmacol 4:218–226.
   PubMed Web of Science ®Google Scholar
• Valentino RJ, Foote SL, Aston-Jones G (1983). Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res 270:363–367.
   PubMed Web of Science ®Google Scholar
• Vale W, Spiess J, Rivier C, Rivier J (1981). Characterization of a 41-residue bovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213:1394–1397.
   PubMed Web of Science ®Google Scholar
• Wochnik GM, Ruegg J, Abel GA, Schmidt U, Holsboer F, Rein T (2005). FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 280:4609–4616.
   PubMed Web of Science ®Google Scholar